Translational Research: Target Identification

One of the first steps in discovering a new therapeutic is identifying a specific molecular target or phenotypic readout for which there is sufficient evidence that it plays a key role in disease progression or symptomology. This may involve approaches utilizing transgenic animals, monitoring signal transduction networks in ex vivo human samples, or genetic studies.

NIDDK-Specific Funding Opportunities

Related Resources

Staff Contacts

Division of Kidney, Urologic, and Hematologic Diseases
Dr. Anna Sadusky

Division of Digestive Diseases and Nutrition
Dr. Bonnie Burgess-Beusse

Division of Diabetes, Endocrinology, and Metabolic Diseases
Dr. Yan Li

For disease area expertise, review the Research Programs and Contacts page.